Votiva Operator Manual DO607094B 37
the treatment area, may be treated only following a prophylactic regime.
Poorly controlled endocrine disorders, such as diabetes or thyroid dysfunction and
hormonal virilization.
Any active skin condition in the treatment area, such as sores, psoriasis, eczema, and rash.
History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile
skin.
History of bleeding coagulopathies.
Any facial surgery performed within a year prior to treatment.
Facial dermabrasion, facial resurfacing, or deep chemical peeling within the last three
months, if face is treated.
Having received treatment with light, laser, RF, or other devices in the treated area within
2-3 weeks for non-ablative procedures, and 6-12 weeks for ablative fractional laser
resurfacing (according to treatment severity) prior to treatment, except special
recommendations.
Use of Isotretinoin (Accutane®) within 6 months prior to treatment.
Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing agents)
one week before and after each treatment session, as per the practitioner’s discretion.
Treating over tattoo or permanent makeup.
Treating over the lips.
Treating over eyebrows or other hair bearing surfaces.
Skin type VI and dark VI patients treat with caution.
Excessively tanned skin from sun, tanning beds or tanning creams and sprays within the
last two weeks.
As per the practitioner's discretion, refrain from treating any condition that might make it
unsafe for the patient.
Possible Adverse Effects
Possible adverse effects include but are not limited by: discomfort or pain, excessive skin
redness (erythema) and/or swelling (edema), damage to natural skin texture (crust, blister,
and burn), change of pigmentation (hyper- and hypo-pigmentation), and scarring.
Erythema lasting not longer than 24h and edema for 1-3 weeks is a typical skin reaction
to the FRACTORA treatment.
Crusting from the ablated dots will exfoliate naturally after 1-3 weeks.
Occasionally, at energy level above 30, there is a potential low-level stimulation of
branches of the facial nerve and there will be some involuntary contraction of the
To Next Page
Loading...
